Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1596

Related Citations for PubMed (Select 9888708)

1.

Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.

Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM.

Am J Surg Pathol. 1999 Jan;23(1):88-96.

PMID:
9888708
2.

Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.

Leinweber B, Colli C, Chott A, Kerl H, Cerroni L.

Am J Dermatopathol. 2004 Feb;26(1):4-13.

PMID:
14726817
3.

Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.

Cerroni L, Signoretti S, Höfler G, Annessi G, Pütz B, Lackinger E, Metze D, Giannetti A, Kerl H.

Am J Surg Pathol. 1997 Nov;21(11):1307-15.

PMID:
9351568
4.

Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases.

Servitje O, Gallardo F, Estrach T, Pujol RM, Blanco A, Fernández-Sevilla A, Pétriz L, Peyrí J, Romagosa V.

Br J Dermatol. 2002 Dec;147(6):1147-58.

PMID:
12452864
5.

Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.

de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM.

Am J Surg Pathol. 2001 Jun;25(6):732-41.

PMID:
11395550
7.

Extranodal marginal zone B-cell lymphoma of the skin: a morphologic and immunophenotypic study of 11 cases.

Tomaszewski MM, Abbondanzo SL, Lupton GP.

Am J Dermatopathol. 2000 Jun;22(3):205-11.

PMID:
10871062
8.

Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization.

Yang B, Tubbs RR, Finn W, Carlson A, Pettay J, Hsi ED.

Am J Surg Pathol. 2000 May;24(5):694-702.

PMID:
10800988
9.

Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases.

Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM.

Ophthalmology. 2000 Jan;107(1):151-8.

PMID:
10647734
10.

Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.

Medeiros LJ, Picker LJ, Abel EA, Hu CH, Hoppe RT, Warnke RA, Wood GS.

J Am Acad Dermatol. 1989 Nov;21(5 Pt 1):929-42.

PMID:
2808829
11.
12.

Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.

Geyer JT, Ferry JA, Longtine JA, Flotte TJ, Harris NL, Zukerberg LR.

Am J Clin Pathol. 2010 Jan;133(1):59-69. doi: 10.1309/AJCPW64FFBTTPKFN.

14.

Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.

Bailey EM, Ferry JA, Harris NL, Mihm MC Jr, Jacobson JO, Duncan LM.

Am J Surg Pathol. 1996 Aug;20(8):1011-23.

PMID:
8712288
15.

Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.

Kazakov DV, Kutzner H, Palmedo G, Boudova L, Michaelis S, Michal M, Vanecek T, Magro CM, Mukensnabl P, Dummer R, Burg G, Kempf W.

Am J Dermatopathol. 2006 Oct;28(5):399-409.

PMID:
17012914
16.
17.
18.

Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients.

Boudova L, Kazakov DV, Sima R, Vanecek T, Torlakovic E, Lamovec J, Kutzner H, Szepe P, Plank L, Bouda J, Hes O, Mukensnabl P, Michal M.

Am J Dermatopathol. 2005 Oct;27(5):375-86.

PMID:
16148405
19.

[Clinicopathologic study of primary marginal zone B-cell lymphoma of MALT type and lymphoid hyperplasia of lung].

Feng RE, Tian XL, Liu HR, Ling Q, Zhong DR, Luo YF, Cao JL, Wan JW, Zhu YJ.

Zhonghua Bing Li Xue Za Zhi. 2008 Mar;37(3):155-9. Chinese.

PMID:
18788590
20.

Mantle zone lymphoma: an immunohistologic study of skin lesions.

Bertero M, Novelli M, Fierro MT, Bernengo MG.

J Am Acad Dermatol. 1994 Jan;30(1):23-30.

PMID:
8277026
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk